Navigation Links
Sanofi-Aventis renews licenses for Genomatix chip analysis pipeline
Date:9/27/2007

Genomatix Software GmbH (Munich) announced today that Sanofi-Aventis has renewed its licenses for Multi-Site access to the Genomatix Microarray Analysis Pipeline.

The pipeline provides a fully integrated, user friendly solution for the analysis of expression and tiling microarray experiments, including the powerful ChIP on chip studies. Genomatix software module ChipInspector seamlessly integrates with additional modules (BiblioSphere PathwayEdition, ElDorado, Gene2Promoter, and GEMS Launcher) to achieve a molecular level understanding of how genes are regulated and co-regulated, providing the scientists at Sanofi-Aventis a comprehensive gene network and pathway analysis.

Martin Seifert, Vice President Microarray Business and Collaborative Research at Genomatix stated: We are pleased that our existing relationship with Sanofi-Aventis has led to an extension of their existing licensing agreement. It confirms the validity of our integrated approach to understanding gene regulation by combining state of the art software, biological data bases, expert systems and scientific support, to provide a complete solution for the computational biologist.


'/>"/>

Contact: Klaus May
may@genomatix.de
49-895-997-660
Genomatix Software GmbH
Source:Eurekalert

0

GOOD

Page: 1

Related medicine news :

1. FDA Gives Green Signal To Sanofi-Aventis SAs Cancer Drug Taxotere
2. Sanofi-Aventis sets the ball rolling for trials of H7N1 bird flu vaccine
3. Sanofi-Aventis Allows Thais To Make Plavix
4. U.N. Secretary-General Ban Renews Goal To Reverse Spread of HIV by 2015
5. US Government Licenses New Hypertension Drug
6. Panacea Biotec In-Licenses FMD Vaccine
7. Thailand Goes Ahead With Licenses for Generic Drugs
8. Swedish Biotech Licenses HIV Drug to China for Development
9. More Foreign Trained Doctors Receive Licenses
10. FDA Licenses First US Vaccine Against Avian Flu
11. Thailand Will Not Issue Compulsory Licenses for Patented Drugs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Children,s Research Hospital and the University o...ollaboration to provide proton therapy for St. Jud...of the first clinical study to evaluate the use of... younger than 3 years old. , Under the clinica...e proton therapy at the UF Proton Therapy Institut...
(Date:11/9/2009)...as 10 million people around the world suffer from ...in Frankfurt and his coauthors discuss cataract su...in the current issue of Deutsches rzteblatt Inter...#65533;). , Blindness is usually due to opacific...,000 cataract operations are performed each year. ...
(Date:11/9/2009)...f seasonal flu could be severe in this group of wo...ealthDay News) -- Pregnant women who are depressed... flu, a new study suggests. , Ohio State Univer...took blood samples from 22 pregnant women before t...ficant symptoms of depression had a stronger infla...
(Date:11/9/2009)... NBC’s Today Show featured a ...Dr. Jill Waibel on Friday Nov. 6th 2009, The segm...s after their first appearance on the Today Show o...Matt Lauer regarding their treatments by Dr. Jill ... TotalFX laser. , (PRWEB)...
(Date:11/9/2009)... Supermodel Beverly Johnson teams w...women suffering in silence understand their uterin... Rockland, MA (PRWEB) November 9, 2009 -- Fib...life altering, says supermodel Beverly Johnson, du...Ask4Tell4, a campaign sponsored by BioSphere Medic...
Breaking Medicine News(10 mins):Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2Health News:Depressed and Pregnant? Flu Shot May Be Needed 2Health News:Lumenis Ultrapulse TotalFX Featured for the Treatment of Burn Scars on the Today Show 2Health News:Lumenis Ultrapulse TotalFX Featured for the Treatment of Burn Scars on the Today Show 3Health News:Lumenis Ultrapulse TotalFX Featured for the Treatment of Burn Scars on the Today Show 4Health News:New Series of Podcasts Highlight Supermodel's "Life-altering" Experience to Raise Awareness of Fibroid Treatment Options 2
...om the American College have recommended that all ...d screening for Down’s Syndrome. // The recommenda... The new guidelines were published in January's is...ocentesis are now widely available, some of that c...
...t on the development of life on our planet, scient...orld" of bacteria// , fungi and other tiny organis...f amber. The microbes existed in the Triassi... A key discovery was that many microbes appear...
...er had once taken a camping trip to Quinault Rain ... which may lead to fatal accidents// . It is repor...nd the mudslides could even throw their tent over ...mountain climbers missing in Oregon. The quest...
...backpack that reduces the weight students and hike...awrence Rome, a biology professor at the Universit..., hikers, athletes and emergency workers, reported...tant level from the ground. The scientist go...
...ining and physical activity may help cure dementia...tellectual abilities// , says a new study. R... University School of Medicine studied about 3,000...Today. Participants who had the training sho...
...ted states, Tamil Nadu has managed to keep the num...support programme// . The Tamilnadu Aids Ini...e become a model for other states to emulate. The ...oday has about 240,000 people suffering from the i...
Other Medicine News:Health News:Micro-world of Prehistoric Bacteria Found in Amber 2Health News:Tamil Nadu Checks AIDS Spread 2Health News:Tamil Nadu Checks AIDS Spread 3
(Date:11/9/2009)..., GLEN ROCK, Pa., Nov. 9 ARma... Inc. announced today an alliance in the developme...D(TM) , an authentication technology that incorpor...ate-release film coatings of solid oral dosage for... provides Colorcon exclusive rights to market ARma...
(Date:11/9/2009)..., BOSTON, Nov. 9 PA...a leading global biopharmaceutical services provid...ac safety capabilities for early phase clinical de...ent, Inc., which manufactures and distributes elec... worldwide. PAREXEL is using Mortara Instrument,s ...
(Date:11/7/2009)..., MIAMI BEACH, Fla., Nov. 7 P...ncentrate is an effective therapy in treating acut... rare and serious genetic disorder, according to d...f Allergy, Asthma & Immunology (ACAAI) Annual ...vey of patients conducted in parallel with the ong...
Breaking Medicine Technology:ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 2ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 3PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 2PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 3PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 4PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 5Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Nestle 28R 29 TOLL HOUSE 28R 29 Refrigerated Cookie Dough Recall Update July 9 2009 51287 1Nestle 28R 29 TOLL HOUSE 28R 29 Refrigerated Cookie Dough Recall Update July 9 2009 51287 22 Fred Hutchinson Cancer Research Center scientists receive Presidential Early Career Award 9197 12 Fred Hutchinson Cancer Research Center scientists receive Presidential Early Career Award 9197 22 Fred Hutchinson Cancer Research Center scientists receive Presidential Early Career Award 9197 32 Fred Hutchinson Cancer Research Center scientists receive Presidential Early Career Award 9197 4RealMed Receives 231 Ranking in the KLAS 2009 Ambulatory Clearinghouse Services Report 51279 1RealMed Receives 231 Ranking in the KLAS 2009 Ambulatory Clearinghouse Services Report 51279 2
...ernational Medical,Corps was selected by American ...jects, ,Saving the Lives of Malnourished Children....P1 ) The project was chosen,out of 1,190 submissio...,five projects to receive the most votes by Septem... five finalists will be announced on September 30 ...
...ased Concurrent with November 9 AHA Data ... Sept. 24 VIA Pharmaceuticals,Inc. (Nasdaq: VIAP...ment of,compounds for the treatment of cardiovascu... the last patient visit in its Phase 2 acute coron...of patients who received an,additional 3 months of...
Other Medicine Technology:International Medical Corps Matched with Top 25 American Express Members Project, 'Saving the Lives of Malnourished Children' 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 4
...nic presents the Streamline family of temporary se...he gold standard in temporary pacing leads and imp... and less traumatic to heart tissue. , ,The St...ovide consistent temporary sensing and pacing duri...
Carbo-Seal Valsalva Ascending Aortic Prosthesis
NDC Lytec Medical 2004 Practice Management Software
PremierEdge™ Stab Knives - 45°
Medicine Products: